Author:
Meaney Paul M,Kaufman Peter A,Muffly Lori S,Click Michael,Poplack Stephen P,Wells Wendy A,Schwartz Gary N,di Florio-Alexander Roberta M,Tosteson Tor D,Li Zhongze,Geimer Shireen D,Fanning Margaret W,Zhou Tian,Epstein Neil R,Paulsen Keith D
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Esserman L: Neoadjuvant chemotherapy for primary breast cancer: lessons learned and opportunities to optimize therapy. Ann Surg Oncol. 2004, 11: 3S-8S. 10.1007/BF02524789.
2. Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB, Fisher ER, Wickerham DL, Wolmark N, DeCillis A, Hoehn JL, Lees AW, Dimitrov NV: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997, 15: 2483-2493.
3. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Tripathy D, Wolverton DS, Rugo HS, Hwang ES, Ewing CA, Hylton NM: MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. Am J Roentgenol. 2005, 184: 1774-1781. 10.2214/ajr.184.6.01841774.
4. American College of Radiology Imaging Network: ACRIN Protocol 6657: contrast-enhanced breast MRI for evaluation of patients undergoing neoadjuvant treatment for locally-advanced breast cancer. 2007, [ http://www.acrin.org/TabID/147/Default.aspx ]
5. Rousseau C, Devillers A, Sagan C, Ferrer L, Bridji B, Campion L, Ricaud M, Bourbouloux E, Doutriaux I, Clouet M, Berton-Rigaud D, Bouriel C, Delecroix V, Garin E, Rouquette S, Resche I, Kerbrat P, Chatal JF, Campone M: Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography. J Clin Oncol. 2006, 24: 5366-5372. 10.1200/JCO.2006.05.7406.
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献